Assignee
OMNIGEN RES L L C
US·7 granted patents·2 pending applications·36 citations·filing 2013–2019
Top patents by PatentIndex Score
9 records- 0188US9173926B2Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune functionOMNIGEN RES L L C·Filed 2013·Granted Nov 3, 2015·8 cites·18 claims
- 0288US8834868B2Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune functionOMNIGEN RES L L C·Filed 2013·Granted Sep 16, 2014·9 cites·21 claims
- 0387US8663644B2Augmentation of titer for vaccination in animalsOMNIGEN RES L L C·Filed 2013·Granted Mar 4, 2014·8 cites·20 claims
- 0486US8828402B2Augmentation of titer for vaccination in animalsOMNIGEN RES L L C·Filed 2014·Granted Sep 9, 2014·7 cites·21 claims
- 0583US11419888B2Composition and method for promoting reduction of heat stress in animalsOMNIGEN RES L L C·Filed 2019·Granted Aug 23, 2022·0 cites·14 claims
- 0680US9114129B2Augmentation of titer for vaccination in animalsOMNIGEN RES L L C·Filed 2014·Granted Aug 25, 2015·3 cites·20 claims
- 0777US10555964B2Composition and method for promoting reduction of heat stress in animalsOMNIGEN RES L L C·Filed 2016·Granted Feb 11, 2020·1 cites·11 claims
- 0865US2018133242A1Composition and method for promoting reduction of heat stress in animalsOMNIGEN RES L L C·Filed 2018·Application pending·0 cites
- 0955US2016129092A1Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune functionOMNIGEN RES L L C·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when OMNIGEN RES L L C files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →